New study checks if IV fat emulsion prevents nutrient shortages in Long-Term patients

NCT ID NCT06049680

Recruiting now Disease control Sponsor: Fresenius Kabi Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 17, 2026 · Updated 1 time

Summary

This study looks at how safe SMOFlipid is for children and adults who need IV nutrition for 8 weeks or more. It checks if the treatment causes a lack of essential fats or liver problems. About 100 participants will be followed to see how their bodies respond.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ESSENTIAL FATTY ACID DEFICIENCY (EFAD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Child Nutrition Disorders Malnutrition nutritional deficiency disease parenteral nutrition-associated cholestasis prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ESSENTIAL FATTY ACID DEFICIENCY (EFAD) MALNUTRITION MALNUTRITION, CHILD PARENTERAL NUTRITION ASSOCIATED CHOLESTASIS

Contacts and locations

Locations

Children's Hospital of Pittsburgh of UPMC
RECRUITING

Pittsburgh, Pennsylvania, 15224, United States
Emory University Hospital
RECRUITING

Atlanta, Georgia, 30322, United States
Nationwide Children's Hospital
RECRUITING

Columbus, Ohio, 43205, United States
Riley Hospital for Children
RECRUITING

Indianapolis, Indiana, 46202, United States
The University of Chicago
NOT_YET_RECRUITING

Chicago, Illinois, 60638, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.